Tocol emulsions for drug solubilization and parenteral delivery.
about
Mechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin.Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma.Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Synthesis and effects of conjugated tocopherol analogues on peptide nucleic acid hybridisation.A critical review of lipid-based nanoparticles for taxane delivery.Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian CarcinomasPM101: intravenous amiodarone formulation changes can improve medication safety.Injectable lipid emulsions-advancements, opportunities and challenges.Lipid nanoparticles for the delivery of poorly water-soluble drugs.Macromolecules as taxane delivery systems.Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives.Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis.Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa."Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters.Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.Formulation of a Novel Nanoemulsion System for Enhanced Solubility of a Sparingly Water Soluble Antibiotic, Clarithromycin
P2860
Q30987265-BD6D9CF9-7815-4C2A-8B3A-15EFDEB9D28EQ33807149-088B51F8-5D50-4893-8F1F-3E300796BA11Q33962553-FB20DAD8-A159-4338-B704-B42E94B40AEBQ34977314-253E987E-7D40-4C82-83B0-B13F00FB305EQ36360764-0EDEB812-5FFB-4991-B411-879912E9D6C1Q37465371-4DC388BA-C74E-4AE6-BC9F-AF00AF835800Q37674638-575DC2A1-D739-42B3-98DC-AAAD79113313Q37803157-DB107A32-F2D1-41DC-B369-39577BA8C6E9Q37805594-1BB0FE34-2801-4E7B-92DC-9F2352809557Q37818236-26F3E508-9335-443D-98CA-2CC55F4796E5Q37818332-C6733880-1155-4839-9613-F38150130D56Q38059498-F699E8CB-F6BE-4935-9E0D-D79B2C1FA8EFQ38973277-7912EEB2-1C1F-48D3-828F-35FBF72962FEQ43262561-59DAD146-EA1C-4D17-B83F-DB30ADBBFC20Q46811884-344666CF-3387-4AE9-858F-9E35505F740AQ47573167-62C6DD0E-31ED-464D-9695-69B7E0BFF585Q51372186-3F16FE4C-8315-41B0-819F-8D3B0E9B7156Q51760290-6D29ECCD-E44D-41EF-BC49-A297862A7E88Q59059831-7A3AEA1A-2780-460D-A149-194C63774416
P2860
Tocol emulsions for drug solubilization and parenteral delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tocol emulsions for drug solubilization and parenteral delivery.
@ast
Tocol emulsions for drug solubilization and parenteral delivery.
@en
type
label
Tocol emulsions for drug solubilization and parenteral delivery.
@ast
Tocol emulsions for drug solubilization and parenteral delivery.
@en
prefLabel
Tocol emulsions for drug solubilization and parenteral delivery.
@ast
Tocol emulsions for drug solubilization and parenteral delivery.
@en
P2093
P1476
Tocol emulsions for drug solubilization and parenteral delivery.
@en
P2093
Alex Tustian
Dean R Kessler
Panayiotis P Constantinides
P304
P356
10.1016/J.ADDR.2003.12.005
P407
P577
2004-05-01T00:00:00Z